Literature DB >> 16500342

Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism.

Balasubramanian Bhagavath1, Robert H Podolsky, Metin Ozata, Erol Bolu, David P Bick, Anita Kulharya, Richard J Sherins, Lawrence C Layman.   

Abstract

OBJECTIVE: To characterize the phenotype, modes of inheritance, karyotype, and molecular basis of patients with idiopathic hypogonadotropic hypogonadism (IHH).
DESIGN: Review of medical records, karyotyping, and collation of gene mutation analysis.
SETTING: University molecular reproductive endocrinology laboratory. PATIENT(S): Patients with IHH. INTERVENTION(S): Review of medical records, laboratory studies, and molecular studies. MAIN OUTCOME MEASURE(S): Sense of smell, severity of IHH (complete vs. incomplete), associated anomalies, karyotype, mutation analysis, and genotype/phenotype correlations were studied. RESULT(S): Of 315 patients with IHH, 6.3% had one or more affected relatives. Autosomal recessive inheritance was likely in most of these familial cases, but autosomal-dominant and X-linked recessive inheritance patterns were likely in some families. Complete IHH was more commonly found in males (62%), whereas incomplete IHH was more commonly observed in females (54.3%). Anosmia was present in 31.3% of males and 27.9% of females. The karyotype was normal in all 19 females tested, but was abnormal in 3 of 57 (5.3%) of males tested. Although cryptorchidism did not differ among those who were anosmic vs. normosmic, it was approximately four times more common in patients with complete IHH than incomplete IHH (15.3% vs. 3.9%). Approximately 10% of the IHH patients tested had mutations in either the GNRHR or KAL1 gene. CONCLUSION(S): Idiopathic hypogonadotropic hypogonadism is a heterogeneous disorder affecting fertility, in which the number of familial cases is probably underestimated. Further study of genes that regulate hypothalamic-pituitary development and function will likely reveal important information regarding the development of normal puberty in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500342     DOI: 10.1016/j.fertnstert.2005.08.044

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  39 in total

1.  Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications.

Authors:  Hilana M Lewkowitz-Shpuntoff; Virginia A Hughes; Lacey Plummer; Margaret G Au; Richard L Doty; Stephanie B Seminara; Yee-Ming Chan; Nelly Pitteloud; William F Crowley; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

Review 2.  Chromodomain proteins in development: lessons from CHARGE syndrome.

Authors:  W S Layman; E A Hurd; D M Martin
Journal:  Clin Genet       Date:  2010-04-08       Impact factor: 4.438

Review 3.  Disorders of pubertal development.

Authors:  Jürgen Brämswig; Angelika Dübbers
Journal:  Dtsch Arztebl Int       Date:  2009-04-24       Impact factor: 5.594

Review 4.  Gynaecomastia--pathophysiology, diagnosis and treatment.

Authors:  Harmeet S Narula; Harold E Carlson
Journal:  Nat Rev Endocrinol       Date:  2014-08-12       Impact factor: 43.330

5.  The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Samuel D Quaynor; Hyung-Goo Kim; Elizabeth M Cappello; Tiera Williams; Lynn P Chorich; David P Bick; Richard J Sherins; Lawrence C Layman
Journal:  Fertil Steril       Date:  2011-10-28       Impact factor: 7.329

6.  Differential expression of nasal embryonic LHRH factor (NELF) variants in immortalized GnRH neuronal cell lines.

Authors:  Samuel D Quaynor; Lindsey Y Goldberg; Eun Kyung Ko; Robert K Stanley; Durkadin Demir; Hyung-Goo Kim; Lynn P Chorich; Richard S Cameron; Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2013-12-04       Impact factor: 4.102

Review 7.  The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Hyung-Goo Kim; Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2011-08-02       Impact factor: 4.102

Review 8.  The genetic basis of female reproductive disorders: etiology and clinical testing.

Authors:  Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

9.  Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.

Authors:  Flavia Amanda Costa-Barbosa; Ravikumar Balasubramanian; Kimberly W Keefe; Natalie D Shaw; Nada Al-Tassan; Lacey Plummer; Andrew A Dwyer; Cassandra L Buck; Jin-Ho Choi; Stephanie B Seminara; Richard Quinton; Dorota Monies; Brian Meyer; Janet E Hall; Nelly Pitteloud; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

10.  Development of an immortalised, post-pubertal gonadotrophin-releasing hormone neuronal cell line.

Authors:  A Wolfe; Y Ng; S A Divall; S P Singh; S Radovick
Journal:  J Neuroendocrinol       Date:  2008-07-09       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.